Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.50 -0.09 (-3.47%)
At close: Nov 10, 2026 · 4:00 PM EST

Galmed Pharmaceuticals (EOCN) Non Operating Income (2013 - 2018)

Updated

Galmed Pharmaceuticals' Non Operating Income was -$516,000 in FY2024, compared with -$580,000 in FY2023.

Analysis

Galmed Pharmaceuticals (EOCN) Non Operating Income (2013 - 2018) Analysis & Trends

From FY2011 onward, Galmed Pharmaceuticals has reported Non Operating Income for 10 years.

  • Annual Non Operating Income has moved between -$580,000 (FY2023) and $215,000 (FY2022) over five years.
  • Per Business Quant data, Non Operating Income in earlier years was -$580,000 in FY2023, $215,000 in FY2022 and -$414,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Galmed Pharmaceuticals 2.06 Mn -38.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2018 90,000.00
Jun 30, 2017 9,000.00
Jun 30, 2016 -89,000.00
Jun 30, 2015 175,000.00
Dec 31, 2014 13,000.00
Sep 30, 2014 16,000.00
Jun 30, 2014 -15,000.00
Mar 31, 2014 26,000.00
Dec 31, 2013 -2.92 Mn
Sep 30, 2013 -5,000.00
Jun 30, 2013 5,000.00
Mar 31, 2013 4,000.00
API Access

Galmed Pharmaceuticals Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=EOCN&period=max&api_key=YOUR_API_KEY